Abstract:Secondary metabolites are organic compounds with complex chemical structures and diverse physiological functions. Secondary metabolites include antibiotics, pigments, and other bioactive compounds. Many of these compounds have important agricultural and medical applications. Microorganisms, especially actinomycetes and filamentous fungi, are noted as a rich source of bioactive secondary metabolites. Typically, each species produces several antibiotics, with the profile being species-specific. Secondary metabolites are synthesized from their precursors through multistep biosynthetic pathways. In general, the genes governing the biosynthesis of secondary metabolites are clustered together, and an increasing number of gene clusters responsible for the biosynthesis of secondary metabolites have been discovered. The availability of clusters has accelerated functional investigations of biosynthetic pathways of secondary metabolites. A thorough understanding of the enzymatic process is required for metabolic engineering to improve production of secondary metabolites and for combinatorial biosynthesis to generate novel compounds or derivatives. Elucidation of the biosynthetic process requires knowledge from diverse disciplines, including bioinformatics, chemistry, and genetics. Secondary metabolites are generally produced during the stationary phase of growth in microorganisms. The biosynthesis of secondary metabolites is a complex process involving cascade regulations, and these regulatory mechanisms have been investigated extensively at the transcriptional level. However, regulation could also occur at the pre-transcriptional and/or post-transcriptional levels. Pretranscriptional regulation occurs primarily at the chromatin level (epigenetic regulation), while post-transcriptional regulation is achieved via small non-coding RNAs (sRNAs) and protein degradation machinery. Though still in its infancy, some interesting progress has been made in this field [1,2]. As antibiotics are the most important of the secondary metabolites, we will focus on antibiotics hereafter. The alarming rise in emergence and prevalence of antibiotic resistance poses a major threat to human healthcare. It is clear that novel antibiotics are urgently needed to combat this problem. However, the supply of new antibiotics has declined in the last decade [3]. To reverse this trend, several strategies have been devised to find or create new antibiotics, which we describe in detail below.

Current research status and vistas on metabolic engineering of nucleoside antibiotics

[Advances of Genome and Secondary Metabolism in Streptomyces].

Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization

Production of pyrimidine nucleosides in microbial systems via metabolic engineering: Theoretical analysis research and prospects

Engineering Nucleoside Antibiotics Toward the Development of Novel Antimicrobial Agents

Natural and Engineered Biosynthesis of Nucleoside Antibiotics in Actinomycetes

Secondary metabolic pathway genes and new drug discovery

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

In silico-guided metabolic engineering of Bacillus subtilis for efficient biosynthesis of purine nucleosides by blocking the key backflow nodes

Microbial Synthesis of Nucleosides: Advances and Prospects

Harnessing synthetic biology-based strategies for engineered biosynthesis of nucleoside natural products in actinobacteria

Engineering fungal secondary metabolism: a roadmap to novel compounds.

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Nucleoside antibiotics: biosynthesis, regulation, and biotechnology.

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics

Progress in strategies for cloning of antibiotics biosynthetic gene clusters

Research progress of medicinal plant secondary metabolic engineering

Biosynthesis and combinatorial biosynthesis of antifungal nucleoside antibiotics

Progress in functional genomics of drug-producing microorganisms

Biosynthesis and Regulation of Secondary Metabolites in Microorganisms

Functional Analysis of Regulatory Components for Antibiotic Biosynthesis